Functions and Specificity of T Cells Following Nucleic Acid Vaccination of Mice Against Mycobacterium tuberculosis Infection

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5921-5926

  Zhu, Xiaojiu ^a   Venkataprasad, Nandagopal ^a   Thangaraj, Harry S ^a   Hill, Mahmuda ^a   Singh, Mahavir ^b   Ivanyi, Juraj ^a   Vordermeier, H Martin ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; EPITOPE; GAMMA INTERFERON;

ANIMAL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PLASMID; SECRETION; TH1 CELL; TUBERCULOSIS; VACCINATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DNA, BACTERIAL; EPITOPES; FEMALE; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TUBERCULOSIS; VACCINATION;

EID: 0031570510     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fine, P. E. M., and L. C. Rodrigues. 1991. Modern vaccines: mycobacterial diseases. Lancet 335:1016.
2. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nature Medicine 2:888.
3. Huygen, K., J. Content, D. Olivier, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. De Witt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J.-P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893.
4. Lai, W. C., M. Bennett, S. A. Johnston, M. A. Barry, and S. P. Pakes. 1995. Protection against Mycoplasma pulmonis infection by genetic vaccination. DNA Cell Biol. 14:643.
5. Martins, L. P., L. L. Lau, M. S. Asano, and R. Ahmed. 1995. DNA vaccination against persistent viral infection. J. Virol. 69:2574.
6. Xu, D., and F. Y. Liew. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84:173.
7. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90:11478.
8. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Howe, and K. R. Leander. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
9. Andersen, A. B., and E. B. Hansen. 1989. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis. Infect Immun. 57:2481.
10. Young, D., L. Kent, A. Rees, J. Lamb, and J. Ivanyi. 1986. Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect. Immun. 54:177.
11. Vordermeier, H. M., D. P. Harris, G. Friscia, E. Roman, H. M. Surcel, C. Moreno, G. Pasvol, and J. Ivanyi. 1992. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur. J. Immunol. 22:2631.
12. Vordermeier, H. M., D. P. Harris, C. Moreno, M. Singh, and J. Ivanyi. 1995. The nature of the immunogen determines the specificity of antibodies and T cells to selected peptides of the 38 kDa mycobacterial antigen. Int. Immunol. 7:559.
13. Singh, M., A. B. Andersen, J. E. McCarthy, M. Rohde, H. Schutte, E. Sanders, and K. N. Timmis. 1992. The Mycobacterium tuberculosis 38-kDa antigen: over-production in Escherichia coli, purification and characterization. Gene 117:53.
14. Harris, D. P., H. M. Vordermeier, S. J. Brett, G. Pasvol, C. Moreno, and J. Ivanyi. 1994. Epitope specificity and isoforms of the mycobacterial 19-kilodalton antigen. Infect. Immun. 62:2963.
15. Vordermeier, H.-M., A. G. A. Coombes, P. Jenkins, J. P. McGee, D. T. O'Hagan, S. S. Davis, and M. Singh. 1995. Synthetic delivery systems for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38-kDa protein entrapped in biodegradable PLG microparticles. Vaccine 13:1576.
16. Vordermeier, H. M., D. P. Harris, E. Roman, R. Lathigra, C. Moreno, and J. Ivanyi. 1991. Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis. J. Immunol. 147:1023.
17. Stauss, H. J., H. Davies, E. Sadovnikova, B. Chain, N. Horowitz, and C. Sinclair. 1992. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. Proc. Natl. Acad. Sci. USA 89:7871.
18. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243.
19. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
20. Vordermeier, H. M., N. Venkataprasad, D. P. Harris, and J. Ivanyi. 1996. Increase in tuberculous infection in the organs of B cell deficient mice. Cell. Exp. Immunol. 106:312.
21. Anacker, R. L., W. R. Barclay, W. Brehmer, G. Goode, R. H. List, H. Ribi, and D. F. Tarmina. 1969. Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv. Am. Rev. Respir. Dis. 99:242.
22. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536.
23. Horwitz, M. A., B. W. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530.
24. Doe, B., M. Selby, S. Barnett, J. Baenzinger, and C. M. Walker. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93:8578.
25. Ulmer, J. B., R. R. Deck, J. J. Dewitt, C. M. Donelly, and M. A. Liu. 1996. Generation of MHC class I restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89:59.
26. Pisetsky, D. S. 1996. The immunologic properties of DNA. J. Immunol. 156:421.
27. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M.-D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352.
28. Kumar, V., and E. Sercarz. 1996. Genetic vaccination: the advantages of going naked. Nature Medicine 2:857.
29. Espitia, C., M. Elinos, P. R. Hernandez, and R. Mancilla. 1992. Phosphate starvation enhances expression of the immunodominant 38-kilodaiton protein antigen of Mycobacterium tuberculosis: demonstration by immunogold electron microscopy. Infect. Immun. 60:2998.
30. De Smet, K. A. L., T. J. Hellyer, A. W. Khan, I. N. Brown, and J. Ivanyi. 1996. Genetic and serovar typing of clinical isolates of the Mycobacterium avium-intracellulare complex. Tubercle and Lung Dis. 77:71.
31. Stanford, J. L., M. J. Shield, and G. A. Rook. 1981. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 62:55.
32. Abou-Zeid, C., T. L. Ratliff, H. G. Wiker, M. Harboe, J. Bennedsen, and G. A. W. Rook. 1988. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect. Immun. 56:3046.
33. Barrios, C., C. Georgopoulos, P. H. Lambert, and G. G. Del. 1994. Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen. Clin. Exp. Immunol. 98:229.
34. Young, D. B., J. Ivanyi, J. H. Cox, and J. R. Lamb. 1987. The 65 kDa antigen of mycobacteria: a common bacterial protein? Immunol. Today 8:215.
35. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481.
36. + T cells of mycobacteria growing in human macrophages. Science 260:984.
37. Gercken, J., J. Pryjma, M. Ernst, and H. D. Flad. 1994. Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 62: 3472.
38. Mazzaccaro, R. J., M. Gedde, E. R. Jensen, H. M. van Santen, H. L. Ploegh, K. L. Rock, and B. R. Bloom. 1996. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 93:11786.
39. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
40. Vordermeier, H. M. 1995. T cell recognition of mycobacterial antigens. Eur. Respir. J. 8 (Suppl. 20):657s.
41. Oldstone, M. B. A., A. Tishon, R. Geckeler, H. Lewicki, and J. L. Whitton. 1992. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implication for vaccination. Prac. Natl. Acad. Sci. USA 89:2752.
42. Sidney, J., H. M. Grey, R. T. Kubo, and A. Sette. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class 1 supermotifs. Immunol. Today 17:261.
43. Lathigra, R., Y. Zhang, M. Hill, M. J. Garcia, P. S. Jackett, and J. Ivanyi. 1996. Lack of production of the 19 kDa glycolipoprotein in certain strains of Mycobacterium tuberculosis. Res. Microbiol. 147:237.
44. Yuan, Y., D. D. Crane, and C. E. Barry. 1996. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the alpha-crystallin homolog. J. Bacteriol. 178:4484.